CNTX – context therapeutics inc. (US:NASDAQ)
Stock Stats
News
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at Wall Stre
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at Wall Stre
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
Context Therapeutics GAAP EPS of -$0.10 misses by $0.01 [Seeking Alpha]
Context Therapeutics (NASDAQ:CNTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Form SCHEDULE 13G/A Context Therapeutics Filed by: Avidity Partners Management LP
Form SCHEDULE 13G/A Context Therapeutics Filed by: GREAT POINT PARTNERS LLC
Form 8-K Context Therapeutics For: Nov 05
Form 10-Q Context Therapeutics For: Sep 30
Form 8-K Context Therapeutics For: Oct 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.